Rackspace (RAX) Revenue, Stock Surges on Cloud


Cloud computing company Rackspace Hosting’s (RAX) revenues and profits are way up as is the company’s stock price, Investor’s Business Daily reported.

Rackspace has made its mark in cloud computing by using an open-source platform know as OpenStack to power its cloud portfolio.

The company launched OpenStack in 2010 and has since built a burgeoning support business around the software, which now has the backing of more than 180 companies.

Rackspace shares have climbed 37% this year and are up 70% from a year ago.

RAX is a Cabot Market Letter stock.

AAPL is a Cabot Top Ten Trader stock.

Like the 974% Gains We Made in Monster Beverage

If you always wanted to test-drive our Cabot Small-Cap Confidential advisory, today is the day.

We're recommending a breakthrough $20 biotech stock that our research shows could hit $40 in the next 12 months--with 20% to 30% gains coming in the next 30 days.

The stock's share price is already up 116% and looks to be rising faster than the 974% we made in Monster Beverage a few years back.

In fact, I so strongly believe that this new recommendation could ultimately become our next Monster Beverage, I want to give you the name of this company free along with a money-back trial subscription to Cabot Small-Cap Confidential.

You'll get not only the full story on this fast moving biotech stock but also on 15 more game-changers that could hand you money-doubling profits— and then some—over the next 12 months.


Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >